×

SECRETORY LEUKOCYTE PROTEASE INHIBITOR DRY POWDER PHARMACEUTICAL COMPOSITIONS

  • US 20010006939A1
  • Filed: 10/03/1997
  • Published: 07/05/2001
  • Est. Priority Date: 10/03/1997
  • Status: Abandoned Application
First Claim
Patent Images

1. A pharmaceutical composition, comprising secretory leukocyte protease inhibitor (SLPI) protein and a pharmaceutically acceptable carrier, wherein said composition is a dry powder of less than about 10% by weight water, and wherein 50% to 95% by mass of said powder comprises particles or agglomerates of particles having a diameter within the range of from about 1.0 microns to about 8 microns with a mass median diameter ranging from about 3.0 microns to about 6 microns.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×